Fund details
Series |
Currency |
Fund code |
MER * (%) |
|---|---|---|---|
| F | CAD | 5410 | 0.99% |
Portfolio analysis As of Feb 28, 2026
99%
1%
Equity
Fixed Income
Asset mix
Equity Sector Allocation
Financials24.9%
Industrials21.3%
Health Care13.0%
Consumer Discretionary11.5%
Consumer Staples7.7%
Information Technology7.5%
Materials4.7%
Communication Services3.2%
Energy3.2%
Utilities3.2%
Unclassified-0.1%
Top 10 Holdings |
% Assets |
|---|---|
| AstraZeneca PLC | 5.1% |
| Safran SA | 4.9% |
| Mitsubishi Electric Corp | 4.8% |
| Unilever PLC | 4.2% |
| Erste Group Bank AG | 4.1% |
| ASML Holding NV | 3.9% |
| InterContinental Hotels Group PLC | 3.9% |
| Siemens Energy AG | 3.7% |
| Sumitomo Mitsui Financial Group Inc | 3.7% |
| Intesa Sanpaolo SpA | 3.6% |
| Total % of Top 10 Holdings | 41.9% |
Geographic allocation
Region
- Europe74.5%
- Asia25.5%
Performance analysis
Growth of $10,000 since inception
Calendar returns
Trailing return
| 1 Mth | 3 Mth | 6 Mth | 1 year | 3 years | 5 years | 10 years | Since Inception | |||
|---|---|---|---|---|---|---|---|---|---|---|
| 5.3 | 10.4 | 17.4 | 22.6 | 13.2 | 5.6 | 8.7 | 4.7 | Fund |
Distribution ($)/unit
| YTD* | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total distributions | 0.00 | 0.38 | 0.32 | 0.38 | 0.21 | 0.13 | 0.05 | 0.25 | 0.18 | 0.16 | 0.23 |
| Interest | --- | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | --- |
| Canadian dividends | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Foreign dividends | --- | 0.40 | 0.36 | 0.40 | 0.21 | 0.13 | 0.06 | 0.27 | 0.20 | 0.17 | 0.25 |
| Foreign taxes paid | --- | -0.03 | -0.04 | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 | -0.02 |
| Capital gains | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return of capital | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
* MER (%) is based on actual expenses for the preceding calendar year or most recent half-year period ended June 30 expressed on an annualized basis, depending on availability of date at the time of publication.